On the public citation graph

The FDA Drug Safety Surveillance Program: Adverse Event Reporting Trends

0 signed · 61 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archinte.165.12.1363openalex-snapshot
Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002
inferredcites →https://doi.org/10.1001/archinte.167.16.1752openalex-snapshot
Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005
inferredcites →https://doi.org/10.1002/pds.615openalex-snapshot
The role of databases in drug postmarketing surveillance

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4856228openalex-extracted
Drug-Induced Liver Injury Associated with Alk Inhibitors: A Pharmacovigilance Analysis of the Fda Adverse Event Reporting System (Faers)
inferred← citeshttps://doi.org/10.1001/jamainternmed.2015.3565openalex-snapshot
Drug Manufacturers’ Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration
inferred← citeshttps://doi.org/10.1002/ajh.23938openalex-snapshot
Cardiovascular and pulmonary adverse events in patients treated with BCR ‐ ABL inhibitors: Data from the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1002/lary.29992openalex-snapshot
Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1002/lio2.70133openalex-snapshot
FDA ‐Approved Biologics for CRSwNP : A Five‐Year Analysis of the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1002/pds.3412openalex-snapshot
Near real‐time adverse drug reaction surveillance within population‐based health networks: methodology considerations for data accrual
inferred← citeshttps://doi.org/10.1002/pds.3805openalex-snapshot
Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants
inferred← citeshttps://doi.org/10.1002/phar.2163openalex-snapshot
Implications of Off‐Target Serotoninergic Drug Activity: An Analysis of Serotonin Syndrome Reports Using a Systematic Bioinformatics Approach
inferred← citeshttps://doi.org/10.1007/978-3-662-43968-5_6openalex-snapshot
Knowledge Discovery and Visualization of Clusters for Erythromycin Related Adverse Events in the FDA Drug Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1007/bf03256860openalex-snapshot
Forum
inferred← citeshttps://doi.org/10.1007/s13300-019-0611-9openalex-snapshot
A Survey of the FDA’s Adverse Event Reporting System Database Concerning Urogenital Tract Infections and Sodium Glucose Cotransporter‐2 Inhibitor Use
inferred← citeshttps://doi.org/10.1007/s13300-020-00771-8openalex-snapshot
SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study
inferred← citeshttps://doi.org/10.1007/s40256-013-0027-2openalex-snapshot
Evaluation and Management of Acquired Methemoglobinemia Associated with Topical Benzocaine Use
inferred← citeshttps://doi.org/10.1007/s40264-013-0115-xopenalex-snapshot
Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
inferred← citeshttps://doi.org/10.1007/s40264-014-0150-2openalex-snapshot
The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
inferred← citeshttps://doi.org/10.1007/s40264-016-0433-xopenalex-snapshot
Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2015.06.003openalex-snapshot
Publisher's Note: Abstraction for data integration: Fusing mammalian molecular, cellular and phenotype big datasets for better knowledge extraction
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2015.08.005openalex-snapshot
Reprint of “Abstraction for data integration: Fusing mammalian molecular, cellular and phenotype big datasets for better knowledge extraction”
inferred← citeshttps://doi.org/10.1016/j.ebiom.2017.11.015openalex-snapshot
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia
inferred← citeshttps://doi.org/10.1016/j.jcjd.2020.12.002openalex-snapshot
“A Touch of Sugar”: A Qualitative Study of the Impact of Health Beliefs on Type 1 and Type 2 Diabetes Self-Management Among Black Canadian Adults
inferred← citeshttps://doi.org/10.1016/j.rmed.2024.107849openalex-snapshot
β-Blockers and Asthma: Surprising findings from the FAERS database
inferred← citeshttps://doi.org/10.1016/j.tips.2014.07.001openalex-snapshot
Lean Big Data integration in systems biology and systems pharmacology
inferred← citeshttps://doi.org/10.1039/c7an01101fopenalex-snapshot
Titanium nanoparticles (TiO 2 )/graphene oxide nanosheets (GO): an electrochemical sensing platform for the sensitive and simultaneous determination of benzocaine in the presence of antipyrine
inferred← citeshttps://doi.org/10.1055/s-0038-1639443openalex-snapshot
Translational Bioinformatics Embraces Big Data
inferred← citeshttps://doi.org/10.1080/02648725.2023.2202541openalex-snapshot
Propofol-associated serious adverse events: an analysis of the FAERS database
inferred← citeshttps://doi.org/10.1080/10408347.2026.2634888openalex-snapshot
Evolving Analytical Techniques for the Determination of Benzocaine and Its Metabolites: A Critical Review
inferred← citeshttps://doi.org/10.1080/14740338.2023.2288897openalex-snapshot
Urinary tract infections and genital mycotic infections associated with SGLT‑2 inhibitors: an analysis of the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1080/17476348.2023.2294927openalex-snapshot
High risks adverse events associated with usage of aspirin in chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1097/mao.0000000000004260openalex-snapshot
A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1109/csci58124.2022.00282openalex-snapshot
Leveraging Data Pathways for Next Generation Safety Monitoring of Medicines and Vaccines
inferred← citeshttps://doi.org/10.1111/bcpt.70271openalex-snapshot
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin
inferred← citeshttps://doi.org/10.1111/jocd.70102openalex-snapshot
Finasteride Use: Evaluation of Depression and Suicide Risk
inferred← citeshttps://doi.org/10.1136/amiajnl-2012-000969openalex-snapshot
The coming age of data-driven medicine: translational bioinformatics' next frontier
inferred← citeshttps://doi.org/10.1167/tvst.15.4.8openalex-snapshot
Signals of Drug-Related Retinal Fibrosis: Findings From a 20-Year Disproportionality Analysis of Global Spontaneous Reports
inferred← citeshttps://doi.org/10.1177/1756283x13491798openalex-snapshot
A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program
inferred← citeshttps://doi.org/10.1177/17562864221129383openalex-snapshot
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1177/2050312119836011openalex-snapshot
Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1177/2050312120974176openalex-snapshot
Assessment of Reye’s syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis
inferred← citeshttps://doi.org/10.1186/2041-1480-3-s1-s5openalex-snapshot
Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes
inferred← citeshttps://doi.org/10.1186/s13023-024-03294-8openalex-snapshot
Drug-associated porphyria: a pharmacovigilance study
inferred← citeshttps://doi.org/10.1186/s13023-025-03864-4openalex-snapshot
Toxicity spectrum of pegvaliase: A pharmacovigilance analysis using the FAERS database
inferred← citeshttps://doi.org/10.1248/bpb.b19-00929openalex-snapshot
Drug Repositioning and Target Finding Based on Clinical Evidence
inferred← citeshttps://doi.org/10.1371/journal.pone.0089324openalex-snapshot
Automated Detection of Off-Label Drug Use
inferred← citeshttps://doi.org/10.1371/journal.pone.0225572openalex-snapshot
Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system
inferred← citeshttps://doi.org/10.1371/journal.pone.0340684openalex-snapshot
Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database
inferred← citeshttps://doi.org/10.14309/00000434-201210001-01733openalex-snapshot
9-Year Evaluation of Temporal Trends in Alosetron Postmarketing Safety Under the Risk Management Program
inferred← citeshttps://doi.org/10.2146/ajhp110262openalex-snapshot
Comparison of rates of reported adverse events associated with i.v. iron products in the United States
inferred← citeshttps://doi.org/10.2147/dhps.s391857openalex-snapshot
Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
inferred← citeshttps://doi.org/10.2147/tcrm.s137144openalex-snapshot
Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs
inferred← citeshttps://doi.org/10.2196/21811openalex-snapshot
Developing a Standardized and Reusable Method to Link Distributed Health Plan Databases to the National Death Index: Methods Development Study Protocol
inferred← citeshttps://doi.org/10.3389/fimmu.2022.778635openalex-snapshot
Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years
inferred← citeshttps://doi.org/10.3390/antibiotics12020240openalex-snapshot
Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database
inferred← citeshttps://doi.org/10.3390/biom11070944openalex-snapshot
Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions
inferred← citeshttps://doi.org/10.3390/molecules27144492openalex-snapshot
Determination of Benzocaine in Pharmaceutical Formulations by Indirect SERRS Assay Combined with Azo Coupling
inferred← citeshttps://doi.org/10.3390/ph18030423openalex-snapshot
Development of a Medication-Related Osteonecrosis of the Jaw Prediction Model Using the FDA Adverse Event Reporting System Database and Machine Learning
inferred← citeshttps://doi.org/10.7150/ijms.6048openalex-snapshot
Data Mining of the Public Version of the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.7150/ijms.7967openalex-snapshot
Commonality of Drug-associated Adverse Events Detected by 4 Commonly Used Data Mining Algorithms
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.